STEICO SE Net Income Over Time
| ST5 Stock | EUR 23.00 0.80 3.36% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out STEICO SE Performance and STEICO SE Correlation. STEICO |
Cross Equities Net Income Analysis
Compare STEICO SE and related stocks such as Abbott Laboratories, DANAHER (DAPSG), and Merck Net Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABL | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 477 M | 2.4 B | 3.7 B | 4.5 B | 7.1 B | 6.9 B | 5.7 B | 13.4 B | 15.4 B | 16.2 B |
| DAP | 2.6 B | 2.6 B | 2.6 B | 2.6 B | 2.6 B | 2.6 B | 2.6 B | 2.5 B | 2.7 B | 3 B | 3.6 B | 6.4 B | 7.2 B | 4.8 B | 3.9 B | 4.5 B | 4.5 B |
| 6MK | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 2.4 B | 6.2 B | 9.8 B | 7.1 B | 13 B | 14.5 B | 365 M | 17.1 B | 19.7 B | 20.7 B |
| AMD | (497 M) | (497 M) | (497 M) | (497 M) | (497 M) | (497 M) | (497 M) | 43 M | 337 M | 341 M | 2.5 B | 3.2 B | 1.3 B | 854 M | 1.6 B | 4.3 B | 4.6 B |
| 4I1 | 7 B | 7 B | 7 B | 7 B | 7 B | 7 B | 7 B | 6 B | 7.9 B | 7.2 B | 8.1 B | 9.1 B | 9 B | 7.8 B | 7.1 B | 11.3 B | 8.9 B |
| W8V | 164.6 B | 164.6 B | 164.6 B | 164.6 B | 164.6 B | 164.6 B | 164.6 B | 172.4 B | 180.1 B | 187.4 B | 192.9 B | 216.6 B | 226.5 B | 231.9 B | 237.8 B | 273.5 B | 221.2 B |
| TOTB | 6.2 B | 6.2 B | 6.2 B | 6.2 B | 6.2 B | 6.2 B | 6.2 B | 8.6 B | 11.4 B | 11.3 B | (7.2 B) | 16 B | 20.5 B | 21.4 B | 15.8 B | 18.1 B | 12.7 B |
| AMG | 7.7 B | 7.7 B | 7.7 B | 7.7 B | 7.7 B | 7.7 B | 7.7 B | 2 B | 8.4 B | 7.8 B | 7.3 B | 5.9 B | 6.6 B | 6.7 B | 4.1 B | 3.7 B | 5 B |
| HBC1 | 16.2 B | 16.2 B | 16.2 B | 16.2 B | 13.7 B | 13.5 B | 2.5 B | 10.8 B | 13.7 B | 7.4 B | 5.2 B | 13.9 B | 15.6 B | 23.5 B | 24 B | 27.6 B | 14.7 B |
| HK2C | 5.8 B | 5.8 B | 5.8 B | 5.8 B | 5.8 B | 5.8 B | 5.8 B | 7.4 B | 9.3 B | 9.4 B | 11.5 B | 12.5 B | 10.1 B | 11.9 B | 13.1 B | 15 B | 11.1 B |
STEICO SE and related stocks such as Abbott Laboratories, DANAHER (DAPSG), and Merck Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in STEICO SE financial statement analysis. It represents the amount of money remaining after all of STEICO SE operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| STEICO SE | ST5 |
Specialization | Basic Materials, Lumber & Wood Production |
| Business Address | Otto-Lilienthal-Ring 30, Feldkirchen, |
| Exchange | Frankfurt Exchange |
EUR 23.0
Other Information on Investing in STEICO Stock
STEICO SE financial ratios help investors to determine whether STEICO Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in STEICO with respect to the benefits of owning STEICO SE security.